Por favor, use este identificador para citar o enlazar a este item:
http://hdl.handle.net/10261/329718COMPARTIR / EXPORTAR:
 SHARE
BASE
|
|
| Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE | |
| Título: | EC50 and CC50 of 39 antiviral drug candidates |
Autor: | Grau-Expósito, Judith; Perea, David; Suppi, Marina; Massana, Nuria; Vergara, Ander; Soler, María José; Trinité, Benjamin; Blanco, Julià; García-Pérez, Javier; Alcamí, José CSIC ORCID; Serrano-Mollar, Anna CSIC ORCID; Rosado, Joel; Falcó, Vicenç; Genesca, Meritxell; Buzón, María José | Palabras clave: | term cell culture structural cell populations preserves main immune susceptible cell targets local inflammatory responses Viral entry inhibitors viral entry factors primary human cells highly reproducible method div >< p alveolar type ii new compounds missed modulate ace2 expression viral targets inflammatory compounds Viral infection new therapeutics 2 entry different compounds without long vitro rapid platform rapid method proteins involved potential therapeutics physiological models pathogen interactions identify host hlt cells hlt ), direct use differentiation approaches conventional systems antiviral testing antiviral activity also show |
Fecha de publicación: | 13-ene-2022 | Editor: | Figshare | Citación: | Grau-Expósito, Judith; Perea, David; Suppi, Marina; Massana, Nuria; Vergara, Ander; Soler, María José; Trinité, Benjamin; Blanco, Julià; García-Pérez, Javier; Alcamí, José; Serrano-Mollar, Anna; Rosado, Joel; Falcó, Vicenç; Genesca, Meritxell; Buzón, María José; 2022; EC50 and CC50 of 39 antiviral drug candidates [Dataset]; Figshare; https://doi.org/10.1371/journal.ppat.1010171.s007 | Versión del editor: | https://doi.org/10.1371/journal.ppat.1010171.s007 | URI: | http://hdl.handle.net/10261/329718 | DOI: | 10.1371/journal.ppat.1010171.s007 | Referencias: | Grau-Expósito, Judith; Perea, David; Suppi, Marina; Massana, Nuria; Vergara, Ander; Soler, María José; Trinité, Benjamin; Blanco, Julià; García-Pérez, Javier; Alcamí, José; Serrano-Mollar, Anna; Rosado, Joel; Falcó, Vicenç; Genesca, Meritxell; Buzón, María José. Evaluation of SARS-CoV-2 entry, inflammation and new therapeutics in human lung tissue cells. https://doi.org/10.1371/journal.ppat.1010171. http://hdl.handle.net/10261/268646 |
| Aparece en las colecciones: | (IIBB) Conjuntos de datos (PTI Salud Global) Colección Especial COVID-19 |
Ficheros en este ítem:
| Fichero | Descripción | Tamaño | Formato | |
|---|---|---|---|---|
| README_s007.txt | 3,39 kB | Text | Visualizar/Abrir | |
| ppat.1010171.s007.docx | 18,15 kB | Microsoft Word XML | Visualizar/Abrir |
CORE Recommender
Page view(s)
44
checked on 27-abr-2024
Download(s)
13
checked on 27-abr-2024
Google ScholarTM
Check
Altmetric
Altmetric
Este item está licenciado bajo una Licencia Creative Commons
